These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 11299816

  • 1. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.
    Koda K, Glassy MC, McKnight ME, Yasutomi J, Saito N, Dan M, Nakajima N.
    Anticancer Res; 2001; 21(1B):621-7. PubMed ID: 11299816
    [Abstract] [Full Text] [Related]

  • 2. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA, John WJ, Chakraborty M, Sherratt A, Garrison J, Flett M, Bhattacharya-Chatterjee M.
    Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
    [Abstract] [Full Text] [Related]

  • 3. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
    Gruber R, van Haarlem LJ, Warnaar SO, Holz E, Riethmüller G.
    Cancer Res; 2000 Apr 01; 60(7):1921-6. PubMed ID: 10766181
    [Abstract] [Full Text] [Related]

  • 4. Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes.
    Fagerberg J, Hjelm AL, Ragnhammar P, Frödin JE, Wigzell H, Mellstedt H.
    Cancer Res; 1995 May 01; 55(9):1824-7. PubMed ID: 7728746
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Schwegler C, Dorn-Beineke A, Nittka S, Stocking C, Neumaier M.
    Cancer Res; 2005 Mar 01; 65(5):1925-33. PubMed ID: 15753392
    [Abstract] [Full Text] [Related]

  • 12. [Expression of tumor-associated antigen LEA and its significance for pathological diagnosis].
    Feng H, Song JD.
    Ai Zheng; 2002 Jun 01; 21(6):658-62. PubMed ID: 12452070
    [Abstract] [Full Text] [Related]

  • 13. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
    Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Kindler HL, Martin EW, Schilsky RL, Goldberg RM, Mayer RJ.
    Ann Surg Oncol; 2008 Jan 01; 15(1):158-64. PubMed ID: 18008108
    [Abstract] [Full Text] [Related]

  • 14. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.
    Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL.
    Clin Cancer Res; 2002 Jul 01; 8(7):2044-51. PubMed ID: 12114402
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.
    Ribas A, Camacho LH, Lopez-Berestein G, Pavlov D, Bulanhagui CA, Millham R, Comin-Anduix B, Reuben JM, Seja E, Parker CA, Sharma A, Glaspy JA, Gomez-Navarro J.
    J Clin Oncol; 2005 Dec 10; 23(35):8968-77. PubMed ID: 16204013
    [Abstract] [Full Text] [Related]

  • 17. Anti-idiotypic antibodies to monoclonal antibody CO17-1A.
    Herlyn D, Sears H, Iliopoulos D, Lubeck M, Douillard JY, Sindelar W, Tempero M, Mellstedt H, Maher M, Koprowski H.
    Hybridoma; 1986 Jul 10; 5 Suppl 1():S51-8. PubMed ID: 3488951
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study.
    Zbar AP, Thomas H, Wilkinson RW, Wadhwa M, Syrigos KN, Ross EL, Dilger P, Allen-Mersh TG, Kmiot WA, Epenetos AA, Snary D, Bodmer WF.
    Int J Colorectal Dis; 2005 Sep 10; 20(5):403-14. PubMed ID: 15864608
    [Abstract] [Full Text] [Related]

  • 20. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.
    Colcher D, Milenic DE, Ferroni P, Carrasquillo JA, Reynolds JC, Roselli M, Larson SM, Schlom J.
    J Nucl Med; 1990 Jul 10; 31(7):1133-42. PubMed ID: 2362192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.